Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NURSE-DELIVERED WRITE SYMPTOMS vs. SELF-DIRECTED WRITE SYMPTOMS vs. CARE AS USUAL FOR OPTIMAL SYMPTOM MANAGEMENT FOR WOMEN WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
調査の概要
状態
詳細な説明
PRIMARY OBJECTIVE:
I. Compare the efficacy of nurse-delivered WRITE Symptoms? and self-directed WRITE Symptoms? vs usual care interventions in improving target symptom representations (i.e., decreases in symptom severity, symptom-related distress, and symptom consequences as measured by the Symptom Representation Questionnaire [SRQ]) in patients with recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer.
SECONDARY OBJECTIVES:
I. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving target symptom representations in these patients at 4 weeks.
II. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving target symptom controllability in these patients at 4, 8, and 12 weeks.
III. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving indicators of quality of life (QOL) of these patients as measured by the FACT-O and the CES-Depression inventory short form at 4, 8, and 12 weeks.
IV. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving communication with health care providers about symptoms, implementation of new symptom management strategies (health care provider recommended as well as patient-initiated changes), and perceived effectiveness of strategies (health care provider recommended as well as patient-initiated changes) in these patients at 4, 8, and 12 weeks.
V. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving patient-related barriers to symptom management as measured by the Symptom Management Barriers Questionnaire at 4, 8, and 12 weeks.
EXPLORATORY OBJECTIVES:
I. Compare trajectories of change for overall symptom severity in patients undergoing nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions using monthly assessments to explore potential long-term effects of the WRITE Symptoms? interventions.
II. Compare trajectories of change for QOL of patients undergoing nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions using monthly assessments to explore potential long-term effects of the WRITE Symptoms? interventions.
III. Compare trajectories of change for symptom severity, distress, communication, and implementation of new strategies for non-targeted symptoms in patients undergoing nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions using monthly assessments to explore whether patients are able to generalize the symptom management approaches taught in WRITE Symptoms? interventions to their other non-targeted symptoms.
IV. Explore whether changes in symptom representations mediate changes in QOL of these patients at 8 and 12 weeks.
V. Explore whether effects of the WRITE Symptoms? interventions on primary and secondary endpoints at 8 and 12 weeks differ based on the following patient characteristics assessed at baseline: age, education, and ethnicity; depression as measured by the CES-D short form; trait anxiety as measured by the STAI; optimism as measured by the LOT-R; social support as measured by the ISEL; and symptom severity as measured by the SRQ.
OUTLINE: This is a multicenter study. Patients are stratified according to race/ethnicity (non-Hispanic white vs Hispanic or non-white). Patients are randomized to 1 of 3 intervention arms.
ARM I (nurse-delivered intervention): Patients are given password-protected access to their own web-based message board to communicate with a research nurse. The nurse leads the patient through the WRITE Symptoms? intervention module comprising representational assessment; exploring concerns/misconceptions/gaps/confusions; creating conditions for conceptual change; introducing new information, goal setting, and development of a symptom management plan; and summary via asynchronous postings to the patient's message board. Patients work through 3 selected symptoms using the nurse-delivered WRITE Symptoms? intervention module over approximately 4 weeks. Two weeks later, the patient's symptom management strategy and their desire to make further changes are evaluated by additional interaction with the nurse via the message board. The nurse will encourage the patient to try new selected strategies, continue with effective strategies, and work with local health care providers in an ongoing process to improve symptom management. Patients are given access to a resource guide that includes self-care guides for 26 symptoms. They are encouraged to use the same process taught for their 3 selected symptoms for any other symptoms that arise after the course of the intervention.
ARM II (self-directed intervention): Patients are given password-protected access to an interactive web-based computer program that will lead them through a modified WRITE Symptoms? intervention module (comprising the same elements as in arm I) without guidance and individualized recommendations from a nurse. Patients work through 3 selected symptoms using the WRITE Symptoms? intervention module over approximately 4 weeks. Two weeks later, patients are prompted by the computer program to respond to questions about their symptom management strategy and their desire to make further changes. The program will generate an encouragement for the patient to try new selected strategies, continue with effective strategies, and continue the new approach to symptom management with local health care providers in an ongoing process to improve symptom management. Patients are given access to a resource guide that includes self-care guides for 26 symptoms. They are encouraged to use the same process taught for their 3 selected symptoms for any other symptoms that arise after the course of the intervention.
ARM III (usual care): Patients are given password-protected access to online questionnaires. Patients are prompted monthly to complete online questionnaires. Patients receive standard symptom management from their local health care providers.
In all arms, patients complete online questionnaires to assess outcome measures at baseline, at 4, 8, and 12 weeks, and then every 4 weeks for 1 year.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Arizona
-
Phoenix、Arizona、アメリカ、85012
- Gynecologic Oncology Group of Arizona
-
-
California
-
Los Angeles、California、アメリカ、90095
- UCLA / Jonsson Comprehensive Cancer Center
-
Los Angeles、California、アメリカ、90048
- Cedars Sinai Medical Center
-
Mountain View、California、アメリカ、94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
-
Colorado
-
Aurora、Colorado、アメリカ、80045
- University of Colorado Hospital
-
-
Connecticut
-
Hartford、Connecticut、アメリカ、06102
- Hartford Hospital
-
New Britain、Connecticut、アメリカ、06050
- The Hospital of Central Connecticut
-
-
Hawaii
-
Honolulu、Hawaii、アメリカ、96813
- Queen's Medical Center
-
Honolulu、Hawaii、アメリカ、96813
- University of Hawaii Cancer Center
-
Honolulu、Hawaii、アメリカ、96826
- Kapiolani Medical Center for Women and Children
-
-
Illinois
-
Decatur、Illinois、アメリカ、62526
- Decatur Memorial Hospital
-
Springfield、Illinois、アメリカ、62781
- Memorial Medical Center
-
Urbana、Illinois、アメリカ、61801
- Carle Cancer Center
-
-
Indiana
-
Elkhart、Indiana、アメリカ、46515
- Elkhart General Hospital
-
Elkhart、Indiana、アメリカ、46514
- Michiana Hematology Oncology PC-Elkhart
-
Elkhart、Indiana、アメリカ、46514-2098
- Elkhart Clinic
-
Indianapolis、Indiana、アメリカ、46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Kokomo、Indiana、アメリカ、46904
- Community Howard Regional Health
-
La Porte、Indiana、アメリカ、46350
- IU Health La Porte Hospital
-
Mishawaka、Indiana、アメリカ、46545
- Michiana Hematology Oncology PC-Mishawaka
-
Mishawaka、Indiana、アメリカ、46545
- Saint Joseph Regional Medical Center-Mishawaka
-
Plymouth、Indiana、アメリカ、46563
- Michiana Hematology Oncology PC-Plymouth
-
South Bend、Indiana、アメリカ、46601
- Memorial Hospital of South Bend
-
South Bend、Indiana、アメリカ、46601
- Michiana Hematology Oncology PC-South Bend
-
South Bend、Indiana、アメリカ、46628
- Northern Indiana Cancer Research Consortium
-
South Bend、Indiana、アメリカ、46617
- South Bend Clinic
-
Westville、Indiana、アメリカ、46391
- Michiana Hematology Oncology PC-Westville
-
-
Iowa
-
Clive、Iowa、アメリカ、50325
- Mercy Cancer Center-West Lakes
-
Clive、Iowa、アメリカ、50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines、Iowa、アメリカ、50309
- Iowa Methodist Medical Center
-
Des Moines、Iowa、アメリカ、50314
- Mercy Medical Center - Des Moines
-
Des Moines、Iowa、アメリカ、50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines、Iowa、アメリカ、50316
- Iowa Lutheran Hospital
-
Des Moines、Iowa、アメリカ、50309
- Iowa-Wide Oncology Research Coalition NCORP
-
Des Moines、Iowa、アメリカ、50314
- Medical Oncology and Hematology Associates-Laurel
-
Iowa City、Iowa、アメリカ、52242
- University of Iowa/Holden Comprehensive Cancer Center
-
West Des Moines、Iowa、アメリカ、50266-7700
- Methodist West Hospital
-
West Des Moines、Iowa、アメリカ、50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66112
- Providence Medical Center
-
Overland Park、Kansas、アメリカ、66209
- Menorah Medical Center
-
Overland Park、Kansas、アメリカ、66213
- Saint Luke's South Hospital
-
Prairie Village、Kansas、アメリカ、66208
- Kansas City NCI Community Oncology Research Program
-
Shawnee Mission、Kansas、アメリカ、66204
- Shawnee Mission Medical Center-KCCC
-
-
Louisiana
-
Shreveport、Louisiana、アメリカ、71105
- CHRISTUS Highland Medical Center
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Bethesda、Maryland、アメリカ、20889-5600
- Walter Reed National Military Medical Center
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02215
- Beth Israel Deaconess Medical Center
-
Boston、Massachusetts、アメリカ、02114
- Massachusetts General Hospital Cancer Center
-
Worcester、Massachusetts、アメリカ、01655
- University of Massachusetts Medical School
-
Worcester、Massachusetts、アメリカ、01605
- University of Massachusetts Memorial Health Care
-
-
Michigan
-
Detroit、Michigan、アメリカ、48201
- Wayne State University/Karmanos Cancer Institute
-
Escanaba、Michigan、アメリカ、49829
- Green Bay Oncology - Escanaba
-
Grand Rapids、Michigan、アメリカ、49503
- Spectrum Health at Butterworth Campus
-
Iron Mountain、Michigan、アメリカ、49801
- Green Bay Oncology - Iron Mountain
-
Kalamazoo、Michigan、アメリカ、49007
- West Michigan Cancer Center
-
Kalamazoo、Michigan、アメリカ、49007
- Bronson Methodist Hospital
-
Kalamazoo、Michigan、アメリカ、49048
- Borgess Medical Center
-
Niles、Michigan、アメリカ、49120
- Lakeland Hospital Niles
-
Royal Oak、Michigan、アメリカ、48073
- William Beaumont Hospital-Royal Oak
-
Saint Joseph、Michigan、アメリカ、49085
- Lakeland Medical Center Saint Joseph
-
Saint Joseph、Michigan、アメリカ、49085
- Marie Yeager Cancer Center
-
-
Minnesota
-
Burnsville、Minnesota、アメリカ、55337
- Fairview Ridges Hospital
-
Coon Rapids、Minnesota、アメリカ、55433
- Mercy Hospital
-
Edina、Minnesota、アメリカ、55435
- Fairview-Southdale Hospital
-
Fridley、Minnesota、アメリカ、55432
- Unity Hospital
-
Hutchinson、Minnesota、アメリカ、55350
- Hutchinson Area Health Care
-
Maplewood、Minnesota、アメリカ、55109
- Saint John's Hospital - Healtheast
-
Maplewood、Minnesota、アメリカ、55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis、Minnesota、アメリカ、55415
- Hennepin County Medical Center
-
Minneapolis、Minnesota、アメリカ、55407
- Abbott-Northwestern Hospital
-
Minneapolis、Minnesota、アメリカ、55455
- University of Minnesota/Masonic Cancer Center
-
New Ulm、Minnesota、アメリカ、56073
- New Ulm Medical Center
-
Robbinsdale、Minnesota、アメリカ、55422
- North Memorial Medical Health Center
-
Saint Louis Park、Minnesota、アメリカ、55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park、Minnesota、アメリカ、55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Paul、Minnesota、アメリカ、55101
- Regions Hospital
-
Saint Paul、Minnesota、アメリカ、55102
- United Hospital
-
Shakopee、Minnesota、アメリカ、55379
- Saint Francis Regional Medical Center
-
Stillwater、Minnesota、アメリカ、55082
- Lakeview Hospital
-
Waconia、Minnesota、アメリカ、55387
- Ridgeview Medical Center
-
Willmar、Minnesota、アメリカ、56201
- Rice Memorial Hospital
-
Woodbury、Minnesota、アメリカ、55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Missouri
-
Kansas City、Missouri、アメリカ、64116
- North Kansas City Hospital
-
Kansas City、Missouri、アメリカ、64111
- Saint Luke's Hospital of Kansas City
-
Kansas City、Missouri、アメリカ、64132
- Research Medical Center
-
Kansas City、Missouri、アメリカ、64108
- Truman Medical Center
-
Kansas City、Missouri、アメリカ、64118
- Heartland Hematology and Oncology Associates Incorporated
-
Kansas City、Missouri、アメリカ、64114
- Saint Joseph Health Center
-
Lee's Summit、Missouri、アメリカ、64086
- Saint Luke's East - Lee's Summit
-
Liberty、Missouri、アメリカ、64068
- Liberty Radiation Oncology Center
-
Saint Joseph、Missouri、アメリカ、64507
- Saint Joseph Oncology Inc
-
Saint Joseph、Missouri、アメリカ、64507
- Heartland Regional Medical Center
-
Saint Louis、Missouri、アメリカ、63110
- Washington University School of Medicine
-
Springfield、Missouri、アメリカ、65807
- CoxHealth South Hospital
-
Springfield、Missouri、アメリカ、65804
- Mercy Hospital Springfield
-
-
Montana
-
Billings、Montana、アメリカ、59101
- Billings Clinic Cancer Center
-
-
Nebraska
-
Omaha、Nebraska、アメリカ、68114
- Nebraska Methodist Hospital
-
Omaha、Nebraska、アメリカ、68198
- University of Nebraska Medical Center
-
-
New Mexico
-
Albuquerque、New Mexico、アメリカ、87102
- University of New Mexico Cancer Center
-
Albuquerque、New Mexico、アメリカ、87106
- Southwest Gynecologic Oncology Associates Inc
-
Las Cruces、New Mexico、アメリカ、88011
- Memorial Medical Center - Las Cruces
-
-
New York
-
Brightwaters、New York、アメリカ、11718
- Island Gynecologic Oncology
-
-
Ohio
-
Akron、Ohio、アメリカ、44307
- Cleveland Clinic Akron General
-
Akron、Ohio、アメリカ、44304
- Summa Akron City Hospital/Cooper Cancer Center
-
Cleveland、Ohio、アメリカ、44106
- Case Western Reserve University
-
Cleveland、Ohio、アメリカ、44109
- MetroHealth Medical Center
-
Cleveland、Ohio、アメリカ、44195
- Cleveland Clinic Foundation
-
Cleveland、Ohio、アメリカ、44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus、Ohio、アメリカ、43214
- Riverside Methodist Hospital
-
Columbus、Ohio、アメリカ、43210
- Ohio State University Comprehensive Cancer Center
-
Dayton、Ohio、アメリカ、45409
- Miami Valley Hospital
-
Mayfield Heights、Ohio、アメリカ、44124
- Hillcrest Hospital Cancer Center
-
Mentor、Ohio、アメリカ、44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
-
Oklahoma
-
Oklahoma City、Oklahoma、アメリカ、73104
- University of Oklahoma Health Sciences Center
-
Tulsa、Oklahoma、アメリカ、74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Pennsylvania
-
Abington、Pennsylvania、アメリカ、19001
- Abington Memorial Hospital
-
Allentown、Pennsylvania、アメリカ、18103
- Lehigh Valley Hospital-Cedar Crest
-
Bryn Mawr、Pennsylvania、アメリカ、19010
- Bryn Mawr Hospital
-
Paoli、Pennsylvania、アメリカ、19301
- Paoli Memorial Hospital
-
Pittsburgh、Pennsylvania、アメリカ、15224
- West Penn Hospital
-
Pittsburgh、Pennsylvania、アメリカ、15213
- UPMC-Magee Womens Hospital
-
Pittsburgh、Pennsylvania、アメリカ、15232
- University of Pittsburgh Cancer Institute (UPCI)
-
Wynnewood、Pennsylvania、アメリカ、19096
- Lankenau Medical Center
-
Wynnewood、Pennsylvania、アメリカ、19096
- Main Line Health NCORP
-
-
Rhode Island
-
Providence、Rhode Island、アメリカ、02905
- Women and Infants Hospital
-
-
South Carolina
-
Charleston、South Carolina、アメリカ、29425
- Medical University of South Carolina
-
-
Texas
-
Houston、Texas、アメリカ、77030
- The Methodist Hospital System
-
-
Virginia
-
Richmond、Virginia、アメリカ、23298
- Virginia Commonwealth University/Massey Cancer Center
-
-
Wisconsin
-
Eau Claire、Wisconsin、アメリカ、54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay、Wisconsin、アメリカ、54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay、Wisconsin、アメリカ、54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay、Wisconsin、アメリカ、54303
- Green Bay Oncology Limited at Saint Mary's Hospital
-
Green Bay、Wisconsin、アメリカ、54301-3526
- Green Bay Oncology at Saint Vincent Hospital
-
Madison、Wisconsin、アメリカ、53792
- University of Wisconsin Hospital and Clinics
-
Manitowoc、Wisconsin、アメリカ、54221
- Holy Family Memorial Hospital
-
Marinette、Wisconsin、アメリカ、54143
- Bay Area Medical Center
-
Marshfield、Wisconsin、アメリカ、54449
- Marshfield Medical Center-Marshfield
-
Milwaukee、Wisconsin、アメリカ、53215
- Aurora Saint Luke's Medical Center
-
Minocqua、Wisconsin、アメリカ、54548
- Marshfield Clinic-Minocqua Center
-
Oconto Falls、Wisconsin、アメリカ、54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rice Lake、Wisconsin、アメリカ、54868
- Marshfield Medical Center-Rice Lake
-
Sturgeon Bay、Wisconsin、アメリカ、54235
- Green Bay Oncology - Sturgeon Bay
-
West Allis、Wisconsin、アメリカ、53227
- Aurora West Allis Medical Center
-
Weston、Wisconsin、アメリカ、54476
- Marshfield Clinic - Weston Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Diagnosis of ovarian, fallopian tube, or primary peritoneal cancer that has recurred or persisted following primary therapy
- Active disease or current treatment are not required
Must be experiencing ? 3 symptoms associated with ovarian cancer or cancer treatment, including, but not limited to, any of the following:
- Abdominal bloating or cramping
- Nausea, vomiting, or diarrhea
- Constipation
- Anorexia
- Anxiety
- Depression
- Dizziness
- Drowsiness
- Dry mouth
- Fatigue
- Headaches
- Hair loss
- Hot flashes
- Memory concerns
- Mood swings
- Mouth sores
- Pain
- Peripheral neuropathies
- Sexuality concerns
- Sleep disturbances
- Shortness of breath
- Skin rash or palmar-plantar erythrodysesthesia
- Urinary problems
- Weight gain or loss
- GOG performance status 0-2
- Able to read and write English
- Access to computer and the Internet required
- Concurrent treatment on other clinical trials allowed
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Arm I (nurse-assisted intervention module)
Patients are given password-protected access to their own web-based message board to communicate with a research nurse.
The nurse leads patients through WRITE Symptoms?
intervention module, with personalized support and advice.
The nurse will encourage the patient to try new selected strategies, continue with effective strategies, and work with local health care providers in an ongoing process to improve symptom management.
|
補助研究
他の名前：
補助研究
補助研究
他の名前：
Ancillary studies
Ancillary studies
他の名前：
Ancillary studies
|
|
実験的：Arm II (self-directed intervention module)
Patients are given password-protected access to an interactive web-based computer program that will lead them through a modified WRITE Symptoms?
intervention module (comprising the same elements as in arm I) without guidance and individualized recommendations from a nurse.
Patients work through 3 selected symptoms using the WRITE Symptoms?
intervention module over approximately 4 weeks.
The program will generate an encouragement for the patient to try new selected strategies, continue with effective strategies, and continue the new approach to symptom management with local health care providers in an ongoing process to improve symptom management.
|
補助研究
他の名前：
補助研究
補助研究
他の名前：
Ancillary studies
他の名前：
Ancillary studies
|
|
アクティブコンパレータ：Arm III (standard care from local provider)
Patients are given password-protected access to online questionnaires.
Patients are prompted monthly to complete online questionnaires.
Patients receive standard symptom management from their local health care providers.
|
補助研究
他の名前：
補助研究
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Symptom severity, symptom-related distress, consequences, and control of symptoms as measured by the Symptom Representation Questionnaire
時間枠：Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Health-related quality of life as measured by the FACT-O
時間枠：Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
|
Depressive symptoms as measured by the CES-D short form
時間枠：Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
|
Communication with health care providers and use of self-care strategies assessed by investigator-developed survey
時間枠：Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
|
Implementation and perceived effectiveness of new symptom management strategies assessed by questionnaire
時間枠：Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
|
Barriers to symptom management as measured by the Symptom Management Barriers Questionnaire
時間枠：Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
協力者と研究者
捜査官
- 主任研究者：Heidi Donovan、Gynecologic Oncology Group
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
再発性卵巣癌の臨床試験
-
Taichung Veterans General Hospital完了心毒性 | 非小細胞肺癌（MeSH用語：Carcinoma, Non-Small-Cell Lung） | 薬物関連の副作用および有害反応（MeSH用語） | EGFRチロシンキナーゼ阻害剤台湾
-
Fondazione del Piemonte per l'Oncologia募集乳がん | 卵巣がん | 結腸直腸がん | 黒色腫 (皮膚がん) | 非小細胞肺癌（MeSH用語：Carcinoma, Non-Small-Cell Lung）イタリア
生活の質の評価の臨床試験
-
Hürriyet YılmazMedipol University完了
-
Bogomolets National Medical University完了
-
Pediatric Clinical Research PlatformUniversity Hospital, Geneva; Swiss Federal Institute of Technology; Hôpital du Valais募集
-
Rostyslav Voloshchukまだ募集していません全身麻酔 | 検証 | 術後の回復 | アンケート